Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2012 Aug 18;33(6):1117–1123. doi: 10.1016/j.cct.2012.08.006

Figure 1. Decision Tree.

Figure 1

Patients enter the model and receive the 21-gene assay or no testing (standard of care). Those who are tested with the 21-gene assay are recommended adjuvant chemotherapy as determined by the recurrence score. All of those who are not tested are recommended adjuvant chemotherapy consistent with current NCCN guidelines. In both strategies there are patients who do not follow the recommendations.